Brinker Capital Investments’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.69M Buy
56,894
+14,571
+34% +$2.23M 0.07% 228
2025
Q4
$5.84M Sell
42,323
-467
-1% -$61.2K 0.04% 378
2025
Q3
$5.49M Buy
42,790
+3,321
+8% +$405K 0.04% 397
2025
Q2
$4.78M Buy
39,469
+4,797
+14% +$541K 0.04% 407
2025
Q1
$3.87M Buy
34,672
+1,051
+3% +$112K 0.04% 429
2024
Q4
$3.27M Buy
33,621
+1,198
+4% +$128K 0.03% 471
2024
Q3
$3.73M Buy
32,423
+1,079
+3% +$122K 0.04% 422
2024
Q2
$3.34M Buy
31,344
+1,976
+7% +$198K 0.04% 427
2024
Q1
$2.84M Sell
29,368
-587
-2% -$60.2K 0.03% 506
2023
Q4
$3.21M Sell
29,955
-1,914
-6% -$185K 0.04% 431
2023
Q3
$3.25M Sell
31,869
-59
-0.2% -$5.99K 0.04% 404
2023
Q2
$3.22M Buy
31,928
+3,088
+11% +$309K 0.03% 455
2023
Q1
$2.65M Sell
28,840
-501
-2% -$43.8K 0.03% 477
2022
Q4
$2.66M Buy
29,341
+861
+3% +$72.5K 0.05% 378
2022
Q3
$2.17M Sell
28,480
-3,092
-10% -$256K 0.04% 431
2022
Q2
$2.67M Sell
31,572
-34,466
-52% -$3.02M 0.05% 364
2022
Q1
$5.79M Buy
66,038
+2,929
+5% +$254K 0.09% 220
2021
Q4
$5.52M Buy
63,109
+3,278
+5% +$272K 0.08% 247
2021
Q3
$5.46M Hold
59,831
0.09% 246
2021
Q2
$5.46M Buy
59,831
+14,207
+31% +$1.27M 0.07% 291
2021
Q1
$3.91M Sell
45,624
-56,277
-55% -$5.05M 0.06% 309
2020
Q4
$9.62M Sell
101,901
-5,772
-5% -$504K 0.15% 153
2020
Q3
$9.38M Buy
+107,673
New +$9.33M 0.16% 155
2020
Q1
Sell
-405
Closed -$38K 607
2019
Q4
$38K Hold
405
﹤0.01% 445
2019
Q3
$35K Sell
405
-136
-25% -$12.2K ﹤0.01% 457
2019
Q2
$49K Buy
541
+317
+142% +$26.8K ﹤0.01% 598
2019
Q1
$19K Buy
224
+125
+126% +$10K ﹤0.01% 562
2018
Q4
$8K Hold
99
﹤0.01% 518
2018
Q3
$8K Buy
+99
New +$7.32K ﹤0.01% 496
2016
Q4
Sell
-75
Closed -$5K 595
2016
Q3
$5K Buy
+75
New +$5.46K ﹤0.01% 416

Other funds holding NVS